Examining attitudes and knowledge about HPV and cervical cancer risk among female clinic attendees in Johannesburg, South Africa

被引:67
作者
Francis, Shelley A. [1 ]
Nelson, Jennifer [2 ]
Liverpool, Joan [3 ]
Soogun, Soji
Mofammere, Nokuthula
Thorpe, Roland J., Jr. [4 ]
机构
[1] Ohio State Univ, Div Hlth Behav & Hlth Promot, Coll Publ Hlth, Smith Lab 3138C, Columbus, OH 43210 USA
[2] Case Western Reserve Univ, Epidemiol & Biostat Dept, Cleveland, OH 44109 USA
[3] Deskan Inst, Stone Mt, GA 30087 USA
[4] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Hlth Dispar Solut, Baltimore, MD USA
关键词
South Africa; HPV; Cervical cancer prevention; HUMAN-PAPILLOMAVIRUS; COST-EFFECTIVENESS; VACCINATION; CHALLENGES;
D O I
10.1016/j.vaccine.2010.08.090
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Developing countries account for 85% of the nearly 500,000 yearly cases of cervical cancer worldwide with approximately 250,000 deaths occurring in Sub-Saharan Africa, South Asia, and Latin America. In South Africa, cervical cancer is the 3(rd) leading cause of death among women. Although cervical cancer can be screened for with regular Pap tests, access to preventive screenings may be nearly non-existent in resource poor settings that have limited public health infrastructure and where women may lack basic health education. Therefore, it is important to understand women's attitudes, knowledge, and beliefs about HPV, cervical cancer, and the HPV vaccine, and assess their access to preventive screening in order to mitigate their risk for developing the disease. Eighty-six women, ages 18-44 with at least one child who presented at an antenatal clinic in a township in Johannesburg were recruited to complete a brief questionnaire. Using both descriptive and multivariate statistics, we assessed knowledge of cervical cancer, HPV, and the vaccine; assessed maternal-child communication about sex and STDs, assessed willingness to vaccinate child; and identified barriers to assessing medical care and the vaccine. The majority of participants were unfamiliar with HPV and cervical cancer, were concerned about their child's and their own risk for HPV and cervical cancer, faced numerous barriers to accessing screening, and were willing to vaccinate their child. Our findings indicate that women in developing countries need increased access to screening and education about HPV and cervical cancer prevention. (c) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:8026 / 8032
页数:7
相关论文
共 25 条
[1]   Introducing HPV vaccine in developing countries - Key challenges and issues [J].
Agosti, Jan M. ;
Goldie, Sue J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (19) :1908-1910
[2]  
[Anonymous], CANC RATES S AFRICA
[3]  
Center for Disease Control and Prevention, HPV STD INF
[4]   Factors that are associated with parental acceptance of human papillomavirus vaccines: A randomized intervention study of written information about HPV [J].
Dempsey, AF ;
Zimet, GD ;
Davis, RL ;
Koutsky, L .
PEDIATRICS, 2006, 117 (05) :1486-1493
[5]  
Dinh TA, 2006, J ADOLESCENT HEALTH, V10, P1016
[6]  
Fisher K., 2006, STOP CERVICAL CANC A
[7]  
Gerhardt C A, 2000, J Pediatr Adolesc Gynecol, V13, P15, DOI 10.1016/S1083-3188(99)00031-5
[8]   Cost-effectiveness of cervical-cancer screening in five developing countries [J].
Goldie, SJ ;
Gaffikin, L ;
Goldhaber-Fiebert, JD ;
Gordillo-Tobar, A ;
Levin, C ;
Mahé, C ;
Wright, TC .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) :2158-2168
[9]   Cost-effectiveness of HPV 16, 18 vaccination in Brazil [J].
Goldie, Sue J. ;
Kim, Jane J. ;
Kobus, Katie ;
Goldhaber-Fiebert, Jeremy D. ;
Salomon, Joshua ;
O'Shea, Meredith K. H. ;
Xavier Bosch, F. ;
de Sanjose, Silvia ;
Franco, Eduardo L. .
VACCINE, 2007, 25 (33) :6257-6270
[10]   Preparing for HPV vaccination in South Africa: Key challenges and opinions [J].
Harries, Jane ;
Moodley, Jennifer ;
Barone, Mark A. ;
Mall, Sumaya ;
Sinanovic, Edina .
VACCINE, 2009, 27 (01) :38-44